4.8 Article

GABAB(1) receptor subunit isoforms differentially regulate stress resilience

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1404090111

关键词

neurogenesis; depression; anxiety; antidepressant

资金

  1. European Commission [7 (FP7)-Health-2007-A-201714]
  2. Science Foundation Ireland (SFI) through Irish Government [02/CE/B124, 07/CE/B1368, SFI/12/RC/2273]
  3. National Center for Competences in Research Synapsy, Synaptic Bases of Mental Health Disease
  4. Swiss National Science Foundation [3100A0-117816]

向作者/读者索取更多资源

Stressful life events increase the susceptibility to developing psychiatric disorders such as depression; however, many individuals are resilient to such negative effects of stress. Determining the neurobiology underlying this resilience is instrumental to the development of novel and more effective treatments for stress-related psychiatric disorders. GABA(B) receptors are emerging therapeutic targets for the treatment of stress-related disorders such as depression. These receptors are predominantly expressed as heterodimers of a GABA(B(2)) subunit with either a GABA(B(1a)) or a GABA(B(1b)) subunit. Here we show that mice lacking the GABA(B(1b)) receptor isoform are more resilient to both early-life stress and chronic psychosocial stress in adulthood, whereas mice lacking GABA(B(1a)) receptors are more susceptible to stress-induced anhedonia and social avoidance compared with wildtype mice. In addition, increased hippocampal expression of the GABA(B(1b)) receptor subunit is associated with a depression-like phenotype in the helpless H/Rouen genetic mouse model of depression. Stress resilience in GABA(B(1b))(-/-) mice is coupled with increased proliferation and survival of newly born cells in the adult ventral hippocampus and increased stress-induced c-Fos activation in the hippocampus following early-life stress. Taken together, the data suggest that GABA(B(1)) receptor subunit isoforms differentially regulate the deleterious effects of stress and, thus, may be important therapeutic targets for the treatment of depression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据